Aprea Therapeutics, Inc. (APRE)
Company Info
ISIN | US03836J1025 |
---|---|
CUSIP | 03836J102 |
Sector | Healthcare |
Industry | Biotechnology |
Highlights
Market Cap | $22.87M |
---|---|
EPS | $12.31 |
PE Ratio | 0.50 |
Revenue (TTM) | $569.16K |
EBITDA (TTM) | -$14.45M |
Year Range | $2.78 - $8.85 |
Target Price | $15.00 |
Short % | 2.23% |
Short Ratio | 4.25 |
Share Price Chart
Loading data...
Compare to other instruments
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Aprea Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Aprea Therapeutics, Inc. had a return of 42.34% year-to-date (YTD) and 47.03% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 42.34% | 10.16% |
1 month | -7.98% | 3.47% |
6 months | 64.52% | 22.20% |
1 year | 47.03% | 30.45% |
5 years (annualized) | N/A | 13.16% |
10 years (annualized) | N/A | 10.89% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 10.00% | 63.64% | ||||||||||
2023 | 19.35% | 12.61% | -19.36% | 8.33% | 29.12% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
This table presents risk-adjusted performance metrics for Aprea Therapeutics, Inc. (APRE) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
Aprea Therapeutics, Inc. | 0.52 | ||||
S&P 500 | 2.79 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Aprea Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aprea Therapeutics, Inc. was 99.71%, occurring on Jul 10, 2023. The portfolio has not yet recovered.
The current Aprea Therapeutics, Inc. drawdown is 99.32%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-99.71% | Dec 30, 2019 | 887 | Jul 10, 2023 | — | — | — |
-24.77% | Nov 20, 2019 | 5 | Nov 26, 2019 | 9 | Dec 10, 2019 | 14 |
-17.45% | Dec 13, 2019 | 4 | Dec 18, 2019 | 4 | Dec 24, 2019 | 8 |
-8.92% | Oct 22, 2019 | 7 | Oct 30, 2019 | 11 | Nov 14, 2019 | 18 |
-7.61% | Oct 4, 2019 | 3 | Oct 8, 2019 | 8 | Oct 18, 2019 | 11 |
Volatility
Volatility Chart
The current Aprea Therapeutics, Inc. volatility is 34.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |